Professional Documents
Culture Documents
Risk factors
Human papillomavirus infection (HPV) Primary factor
HPV 16, HPV 18, HPV 31, HPV 33, HPV 45
50-70% are caused by HPV 16 AND 18
Sexual behavior
Smoking
HIV infection
Chlamydia infection
Diet
Oral contraceptives
Multiple pregnancies
Low socioeconomic status
Diethylstilbestrol (DES)
Family history
Pathogenesis
Epitheliotropic
5 genera alfa, beta, gamma, mu,
nu
HPV can be identified in >99% of
cervical cancers.
Necessary but not sufficient
Most infections are transient.
Persistence of infection is a risk
factor.
Persist as Autonomous replicating extrachromosomal elements or episomes(most
commonly, integration into host DNA seen in
high grade CIN/ Carcinoma)
Screening
Conventional
Advantages:
- Low cost
- No specia
equipment
Disadvantages:
- Lack of uniformity
in specimen
preparation
- Unsatisfactory
smears
Liquid based
Advantages:
- Uniformity
- Less unsatisfactory
samples
Disadvantages:
- Higher cost
- Special equipment
needed
Classification systems
LSIL
HSIL
HPV testing
Using hybrid capture 2 and PCR.
When combined with Pap smear :
- Higher negative predictive value of >95%
- Sensitive in detecting High grade dysplasia
Hybrid capture technique has excellent
interlaboratory reliability and reproducibility
Useful in women >30yrs
Testing discouraged below 30yrs.
Sherman et al., Clavel et al.,
Screening recommendations
Colposcopy
Examination of lower genital tract vulva, vagina
and cervical epithelium and opening of
endocervix.
Acetic acid and Lugols solution(Schillers test)
used to highlight abnormal and dysplastic
changes
Suspicious lesions biopsied:
- Aceto white plaques
- Vascular abnormalities punctations, mosaicism,
abnormal branching
Indications:
- Abnormal appearing cervix
- Persistent post coital bleeding /
discharge
- Persistent CIN 1,2,3 o cytology
- In utero exposure to DES
- ASCUS smears with positive high risk
HPV testing
Conization biopsy
Surgical removal of Squamocolumnar junction
- Classical cold knife technique
- Thermal cautery with loop excision
Indications:
- Inadequate colposcopy
- Positive ECC
- Persistent CIN 1(>1yr), CIN2,3,or CIS
- Discrepancy between Cytologic,
colposcopic or pathologic findings
Staging evaluation
Clinical examination is the predominant
tool for staging cervical cancer.
- Pelvic examination including PV and DRE
- CXR, Cystoscopy, Sigmoidoscopy,
Barium enema, Examination under
anesthesia are optional
- MRI pelvis for tumor diameter, uterine
extension, and parametrial extension
esp in early cancer.
FIGO staging
Clinical
FIGO does not incorporate evidence of lymph
node metastasis gained by surgical staging
or advanced imaging studies in the stage
Surgical findings and radiographically guided
biopsies of suspected lesions such as LN or
lung metastasis cannot be used to modify
clinical FIGO staging.
If there is ambiguity regarding the correct
stage, the lower stage is assigned.